Published in J Magn Reson Imaging on March 08, 1996
Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J Clin Invest (2001) 1.32
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action. Biologics (2013) 0.92
A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis. J Neurol (2007) 0.88
Monoclonal antibodies as disease modifying therapy in multiple sclerosis. Curr Neurol Neurosci Rep (2013) 0.79
Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC. J Clin Immunol (2007) 0.78
The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain (1989) 5.59
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56
Cytomegalovirus and Rasmussen's encephalitis. Lancet (1990) 2.96
The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain (1989) 2.59
A cell culture model of the blood-brain barrier. J Cell Biol (1991) 2.35
The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain (1991) 2.11
Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J Immunol (1988) 2.01
Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production. J Exp Med (1984) 1.92
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain (1999) 1.91
The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis. Neurology (1998) 1.58
A population-based study of multiple sclerosis in twins: update. Ann Neurol (1993) 1.46
HTLV-1 associated myelopathy in Canada. Can J Neurol Sci (1989) 1.40
Interaction of aluminum species with deoxyribonucleic acid. Biochemistry (1980) 1.39
Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging (2000) 1.37
Systemic alpha-interferon therapy of multiple sclerosis. Neurology (1984) 1.35
The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. Brain (1991) 1.25
A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology (1984) 1.24
Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis (1986) 1.22
A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol (1995) 1.20
Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8. J Neuroimmunol (1984) 1.18
VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. J Neuroimmunol (2009) 1.15
Cytomegalovirus infection of peripheral blood mononuclear cells: effects on interleukin-1 and -2 production and responsiveness. J Virol (1988) 1.13
Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J Neurochem (1991) 1.12
The prevalence of primary Sjögren's syndrome in a multiple sclerosis population. Ann Neurol (1989) 1.10
Cytomegalovirus in the brain: in vitro infection of human brain-derived cells. J Infect Dis (1990) 1.10
The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation. J Infect Dis (1994) 1.10
The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis. Brain (2000) 1.10
Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res (1983) 1.07
A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology (1992) 1.05
HIV-1 infection of human brain-derived microvascular endothelial cells in vitro. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.04
Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis. Hum Antibodies (1997) 1.00
Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol (1992) 0.99
Role of the monocyte in cytomegalovirus-mediated immunosuppression in vitro. J Infect Dis (1986) 0.98
VEGF and vascular changes in chronic neuroinflammation. J Autoimmun (2003) 0.98
Variation in immunoglobulin G and albumin concentrations during lumbar CSF removal: a reappraisal. Neurology (1982) 0.98
A new solid-phase enzyme-linked immunosorbent assay for specific antibodies to measles virus. J Infect Dis (1983) 0.95
Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer. J Urol (1996) 0.93
Role of the adrenal cortex in gastric mucosal protection by prostaglandins, sulfhydryls, and cimetidine in the rat. Gastroenterology (1983) 0.93
Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain. J Magn Reson Imaging (1994) 0.92
Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment. J Am Acad Dermatol (1989) 0.91
Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin. J Neuroimmunol (2002) 0.90
The effect of cladribine on T(1) 'black hole' changes in progressive MS. J Neurol Sci (2000) 0.89
Computational blood flow modeling based on in vivo measurements. Ann Biomed Eng (1999) 0.87
Extramedullary hematopoiesis and spinal cord compression complicating polycythemia rubra vera. Ann Neurol (1980) 0.87
Mollaret's meningitis associated with herpes simplex type 2 infection. Neurology (1993) 0.86
Cerebellar astrocytoma with benign histology and malignant clinical course. Case report. J Neurosurg (1981) 0.86
Hyperbaric oxygen therapy in chronic stable multiple sclerosis: double-blind study. Neurology (1986) 0.85
Differentiation of parenchymal lung disorders with in vitro proton nuclear magnetic resonance. Magn Reson Med (1986) 0.85
Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis. Can J Neurol Sci (1988) 0.84
An open-trial evaluation of mitoxantrone in the treatment of progressive MS. Neurology (1993) 0.84
Connexin 43 gap junction proteins are up-regulated in remyelinating spinal cord. J Neurosci Res (2007) 0.84
NMR studies in experimental allergic encephalomyelitis (EAE): normalization of T1 and T2 with parenchymal cellular infiltration. Neurology (1986) 0.84
Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy. Ann Neurol (1986) 0.84
Myopathy in primary systemic amyloidosis. Can J Neurol Sci (1988) 0.84
Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Ann Neurol (1983) 0.83
Selective spinal cordectomy: clinicopathological correlation. J Neurosurg (1982) 0.83
NMR changes in experimental allergic encephalomyelitis: NMR changes precede clinical and pathological events. Magn Reson Med (1987) 0.82
Diagnostic brain MRI findings in primary progressive multiple sclerosis. Mult Scler (2000) 0.82
Recurrent cerebral embolism in cardiac amyloidosis. Neurology (1981) 0.81
Experimental allergic encephalomyelitis in connexin 43-heterozygous mice. Cell Commun Adhes (2007) 0.81
Similarities of guamanian ALS/PD to post-encephalitic parkinsonism/ALS: possible viral cause. Can J Neurol Sci (1990) 0.81
Ondansetron for intractable vertigo complicating acute brainstem disorders. Lancet (1995) 0.81
In vivo measurements of multi-component T2 relaxation behaviour in guinea pig brain. Magn Reson Imaging (1999) 0.81
Cysteamine-induced adrenocortical necrosis in rats. Exp Mol Pathol (1981) 0.80
An open trial of OKT3 in patients with multiple sclerosis. Neurology (1991) 0.80
Pathogenesis of experimental adrenal hemorrhagic necrosis ("apoplexy"): ultrastructural, biochemical, neuropharmacologic, and blood coagulation studies with acrylonitrile in the rat. Lab Invest (1980) 0.80
Nucleotide sequence analysis of an HTLV-I isolate from a Chilean patient with HAM/TSP. AIDS Res Hum Retroviruses (1992) 0.80
Reduced visual evoked responses in multiple sclerosis patients with optic neuritis: comparison of functional magnetic resonance imaging and visual evoked potentials. Mult Scler (1999) 0.80
Interpretation of single band patterns in CSF protein electrophoresis. Can J Neurol Sci (1988) 0.79
Retroviruses and multiple sclerosis. I. Analysis of seroreactivity by western blot and radioimmune assay. Neurology (1990) 0.79
Producing picture-perfect posters. AJR Am J Roentgenol (1993) 0.79
Evidence for a prolonged role of alpha 4 integrin throughout active experimental allergic encephalomyelitis. Neurology (1996) 0.79
Possible mechanism by which stress accelerates growth of virally derived tumors. Proc Natl Acad Sci U S A (1992) 0.78
Subacute and chronic action of acrylonitrile on adrenals and gastrointestinal tract: biochemical, functional and ultrastructural studies in the rat. J Appl Toxicol (1984) 0.78
Resolution-dependent estimates of multiple sclerosis lesion loads. Can J Neurol Sci (2005) 0.78
Cytomegalovirus-caused release of collagenase IV from human cerebral microvascular endothelial cells. Clin Diagn Virol (1995) 0.78
Acute toxicity of some silver salts of sulfonamides in mice and the efficacy of penicillamine in silver. Drug Chem Toxicol (1983) 0.78
Human T-lymphotropic virus type 1 in coastal natives of British Columbia: phylogenetic affinities and possible origins. J Virol (1995) 0.78
Familial stroke syndrome associated with mitral valve prolapse. Ann Neurol (1980) 0.78
Trichlorethylene poisoning mimicking multiple sclerosis. Can J Neurol Sci (1988) 0.78
The failure of monoclonal antibody-defined lymphocyte subsets to monitor disease activity in patients with multiple sclerosis. Ann N Y Acad Sci (1984) 0.77
Immune balance in the cytomegalovirus-infected host: in vitro studies of virus-lymphocyte interactions and the effects on specific lymphocyte function. Birth Defects Orig Artic Ser (1984) 0.77
Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor. J Urol (1997) 0.77
Common pharmaceuticals alter tissue proton NMR relaxation properties. Magn Reson Med (1986) 0.77
Magnetic resonance imaging of small medullary infarctions. AJNR Am J Neuroradiol (1986) 0.77
Hand wasting due to mid-cervical spinal cord compression. Can J Neurol Sci (1987) 0.77
Gadolinium-DTPA enhanced MRI demonstrates uterine vascular changes associated with artificially induced decidualization and ovoimplantation in rats. Magn Reson Med (1993) 0.77
Early identification of sites of embryo implantation in rats by means of gadolinium-enhanced MR imaging. J Magn Reson Imaging (1994) 0.77
Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat. J Pharmacol Exp Ther (1987) 0.77
HTLV-I infection associated with disease in aboriginal Indians from British Columbia: a serological and PCR analysis. Clin Diagn Virol (1994) 0.77
Stability studies on chemoembolization mixtures. Dialysis studies of doxorubicin and lipiodol with Avitene, Gelfoam, and Angiostat. Invest Radiol (1993) 0.77
New developments with herpesviruses and the nervous system. Curr Opin Neurol Neurosurg (1993) 0.76
Differential effect of changing central and peripheral catecholamine levels in cysteamine-induced duodenal ulcer in the rat. Life Sci (1981) 0.76
Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis. Scand J Immunol (1994) 0.76
Reduction of sunburn damage to skin by topical application of vitamin E acetate following exposure to ultraviolet B radiation: effect of delaying application or of reducing concentration of vitamin E acetate applied. Scanning Microsc (1993) 0.76
Encephalopathy in liver transplantation: neuropathology and CMV infection. Can J Neurol Sci (1990) 0.76